Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Daniel Winn, MD

Articles by Daniel Winn, MD

CKD Quality Improvement Intervention With PCMH Integration: Health Plan Results

ByJoseph A. Vassalotti, MD,Rachel DeVinney, MPH, CHES,Stacey Lukasik, BA,Sandra McNaney, BS,Elizabeth Montgomery, BS,Cindy Voss, MA,Daniel Winn, MD

November 8th 2019

A scalable chronic kidney disease (CKD) quality improvement intervention demonstrated feasibility, decreased hospitalization, and reduced costs. These preliminary results support innovation in CKD by commercial health plans.

Physician Behavior Impact When Revenue Shifted From Drugs to Services

ByBruce Feinberg, DO,Scott Milligan, PhD,Tim Olson, MBA,Winston Wong, PharmD,Daniel Winn, MD,Ram Trehan, MD,Jeffrey Scott, MD

April 21st 2014

Shifting physician revenue from drug sales to cognitive services for mature pathways providers did not affect practice behavior in this payer-sponsored Oncology Medical Home.

Third-Party Validation of Observed Savings From an Oncology Pathways Program

ByBruce A. Feinberg, DO,Scott Milligan, PhD,Joseph Cooper, BS,Winston Wong, PharmD,Daniel Winn, MD,Neil Schneider, ASA, MAAA,Sheamus Parkes, FSA, MAAA,Jeffrey Scott, MD

June 18th 2013

Latest Updated Articles

CKD Quality Improvement Intervention With PCMH Integration: Health Plan Results
November 8th 2019
Third-Party Validation of Observed Savings From an Oncology Pathways Program
June 18th 2013
Physician Behavior Impact When Revenue Shifted From Drugs to Services
April 21st 2014

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

SYNCHRONIZE-1 Through a Hepatologist's Lens: Liver Fat Reduction, Visceral Fat, and What Comes Next

Stem Cell Transplant Outperforms DMTs in Drug-Resistant Relapsing MS

5 Things to Know About Dry Eye During Awareness Month

Deep Learning Model Matches Expert Agreement in Sleep Arousal Scoring